Source: Citybizlist

OncoResponse: OncoResponse Raises $14M in Funding

OncoResponse, a Seattle, WA-based clinical-stage biotech company, raised $14M in funding. The round was led by RiverVest Venture Partners and... Read More The post OncoResponse Raises $14M in Funding appeared first on citybiz.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Clifford J Stocks's photo - CEO of OncoResponse

CEO

Clifford J Stocks

CEO Approval Rating

90/100

Read more